Publication:
Erratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44-S45].

dc.contributor.authorJanni, Wolfgang
dc.contributor.authorChan, Arlene
dc.contributor.authorNusch, Arnd
dc.contributor.authorAlba, Emilio
dc.contributor.authorBachelot, Thomas
dc.contributor.authorGil-Gil, Miguel
dc.contributor.authorKattan, Joseph
dc.contributor.authorBourgeois, Hugues
dc.contributor.authorEl Karak, Fadi
dc.contributor.authorSutradhar, Santosh
dc.contributor.authorMiller, Michelle
dc.contributor.authorChandiwana, David
dc.contributor.authorConte, Pierfranco
dc.date.accessioned2023-01-25T10:20:54Z
dc.date.available2023-01-25T10:20:54Z
dc.date.issued2018
dc.identifier.doi10.1016/j.breast.2018.04.007
dc.identifier.essn1532-3080
dc.identifier.pmid30005916
dc.identifier.unpaywallURLhttp://www.thebreastonline.com/article/S0960977618300705/pdf
dc.identifier.urihttp://hdl.handle.net/10668/12708
dc.journal.titleBreast (Edinburgh, Scotland)
dc.journal.titleabbreviationBreast
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.page.number53
dc.pubmedtypeJournal Article
dc.pubmedtypePublished Erratum
dc.rights.accessRightsopen access
dc.titleErratum to "First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results" [Breast 36 (Suppl. 1) (November 2017) S44-S45].
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number40
dspace.entity.typePublication

Files